DR. ERIC JAMES JOHNSON, D.C.
Chiropractic at Big Sky Dr, Madison, WI
License number
Wisconsin 5260-12
Category
Chiropractic
Type
Chiropractor
Address
Address
7818 Big Sky Dr SUITE 215, Madison, WI 53719
Phone
(608) 203-9272
(608) 203-9271 (Fax)
(608) 203-9271 (Fax)
Professional information
Feng Shui Real Estate Advisor
Position:
sales associate at Matson & Assoc. Inc., Real Living, Owner at Stebbinsville Benchworks
Location:
Madison, Wisconsin Area
Industry:
Real Estate
Work:
Matson & Assoc. Inc., Real Living
-
sales associate
Stebbinsville Benchworks
since 2011
-
Owner
Education:
U of Delaware and Maryland State U 1974 - 1978
Interests:
Study of Feng Shui in Real Estate, Wooden boat building, Canoe and Kayak Paddling, Camping, Fishing, Selling Rural Properties.
Chimeric Toxins
US Patent:
6545126, Apr 8, 2003
Filed:
Mar 14, 2000
Appl. No.:
09/524841
Inventors:
Eric A. Johnson - Madison WI
Michael C. Goodnough - Stoughton WI
Carl J. Malizio - Madison WI
Alan B. Scott - San Francisco CA
Michael C. Goodnough - Stoughton WI
Carl J. Malizio - Madison WI
Alan B. Scott - San Francisco CA
Assignee:
Wisconsin Alumni Research Foundation - Madison WI
International Classification:
C07K 14195
US Classification:
530350, 530370, 514 2, 514 12, 424 946
Abstract:
A chimeric toxin is disclosed. In a preferred embodiment, the chimeric toxin comprises a botulinal neurotoxin heavy chain and non-clostridial toxin chain. A method of creating a chimeric toxin is also disclosed. The chimeric toxin will have utility for pharmacological treatment of neurological disorders.
Astaxanthin-Producing Yeast Cells, Methods For Their Preparation And Their Use
US Patent:
5356810, Oct 18, 1994
Filed:
Jul 27, 1992
Appl. No.:
7/919986
Inventors:
Bent Fleno - Stenlose, DK
Ib Christensen - Allerod, DK
Robert Larsen - Virum, DK
Steffen R. Johansen - Ega, DK
Eric A. Johnson - Madison WI
Ib Christensen - Allerod, DK
Robert Larsen - Virum, DK
Steffen R. Johansen - Ega, DK
Eric A. Johnson - Madison WI
Assignee:
Gist-brocades N.V.
International Classification:
C12N 116, C12P 2300
US Classification:
4352251
Abstract:
An isolated pure culture of a strain of Phaffia rhodozyma which produces astaxanthin in an amount of at least 600. mu. g per g Phaffla rhodozyma dry matter, as determined by HPLC analysis.
Method Of Inhibiting Pathogens And Food Spoilage Bacteria
US Patent:
5455278, Oct 3, 1995
Filed:
Sep 19, 1994
Appl. No.:
8/308779
Inventors:
June F. M. Parreiras - Vicosa, BR
Eric A. Johnson - Madison WI
Eric A. Johnson - Madison WI
Assignee:
Wisconsin Alumni Research Foundation - Madison WI
International Classification:
A01N 3114, A23L 334
US Classification:
514723
Abstract:
A method of inhibiting gram-positive bacteria in a medium, such as food, comprises adding to the medium an effective amount of an inhibitor from carrots or a derivative thereof. Compositions and products containing such an inhibitor are also disclosed.
Processes For In Vivo Production Of Astaxanthin And Phaffia Rhodozyma Yeast Of Enhanced Astaxanthin Content
US Patent:
5356809, Oct 18, 1994
Filed:
Feb 14, 1992
Appl. No.:
7/837120
Inventors:
Eric A. Johnson - Madison WI
Huei-hsiung Yang - Rockville MD
Beril Geldiay-Tuncer - Bostanli-Karsiyaka, TR
William T. Hall - Rockville MD
David Schreiber - Columbia MD
Kwok Ho - San Diego CA
Huei-hsiung Yang - Rockville MD
Beril Geldiay-Tuncer - Bostanli-Karsiyaka, TR
William T. Hall - Rockville MD
David Schreiber - Columbia MD
Kwok Ho - San Diego CA
Assignee:
Igene Biotechnology, Inc. - Columbia MD
International Classification:
C12N 116, C12P 2300
US Classification:
4352551
Abstract:
An economical process for in vivo production of the pigment astaxanthin, and particularly a process for enhancing astaxanthin content of cultures of microorganisms of genus Phaffia, the process comprising culturing a microorganism of genus Phaffia in a nutrient medium containing an antibiotic, a cytochrome B inhibitor, or a terpenoid synthetic pathway inhibitor, cultivating surviving pigment enhanced microorganisms, and harvesting the yeast.
Hybrid Botulinal Neurotoxins
US Patent:
5939070, Aug 17, 1999
Filed:
Oct 28, 1996
Appl. No.:
8/739477
Inventors:
Eric A. Johnson - Madison WI
Michael C. Goodnough - Stoughton WI
Marite Bradshaw - Madison WI
Michael C. Goodnough - Stoughton WI
Marite Bradshaw - Madison WI
Assignee:
Wisconsin Alumni Research Foundation - Madison WI
International Classification:
A61K 39385, A61K 3908, C12P 2106, C12N 952
US Classification:
4241941
Abstract:
A hybrid botulinal neurotoxin is disclosed. In one embodiment, the neurotoxin comprises a combination of a botulinal neurotoxin heavy chain and light chain, wherein the light chain and heavy chain are not of the same serotype. A method for creating hybrid neurotoxins comprised of different functional domains is also disclosed.
Method Of Sensitizing Microbial Cells To Antimicrobial Compound
US Patent:
6319958, Nov 20, 2001
Filed:
Jun 22, 1998
Appl. No.:
9/102466
Inventors:
Eric A. Johnson - Madison WI
Byron F. Brehm-Stecher - Madison WI
Byron F. Brehm-Stecher - Madison WI
Assignee:
Wisconsin Alumni Research Foundation - Madison WI
International Classification:
A01N 3100, C07C 3500
US Classification:
514739
Abstract:
A method of promoting the uptake of exogenous antimicrobial compounds by microbial cells is disclosed. In one embodiment, the method comprises the step of exposing the microbial cell to an amount of at least one sesquiterpenoid effective to enhance antimicrobial compound uptake in a microorganism and an antimicrobial compound. An antimicrobial composition comprising at least one sesquiterpenoid and an antimicrobial compound, the sesquiterpenoid being present in a concentration of between 0. 1 mM and 50 mM, is also disclosed.
Purification Of Type G Botulinum Neurotoxin And Pharmaceutical Compositions Thereof
US Patent:
5846929, Dec 8, 1998
Filed:
Apr 16, 1996
Appl. No.:
8/633092
Inventors:
Eric A. Johnson - Madison WI
Hiroshi Sugiyama - Madison WI
Carl J. Malizio - Madison WI
Hiroshi Sugiyama - Madison WI
Carl J. Malizio - Madison WI
Assignee:
Wisconsin Alumni Research Foundation - Madison WI
International Classification:
A61K 3800, A23J 100, C12P 2104
US Classification:
514 2
Abstract:
The isolation and purification of type G botulinum neurotoxin and complexes thereof is disclosed. Compositions containing the type G neurotoxin and the preparation of a type G toxoid are also disclosed.
Device And Methods For Liquid Crystal-Based Bioagent Detection
US Patent:
7910382, Mar 22, 2011
Filed:
Oct 31, 2006
Appl. No.:
11/555103
Inventors:
Nicholas L. Abbott - Madison WI, US
Sarah Teren - Madison WI, US
David J. Beebe - Monona WI, US
Eric A. Johnson - Madison WI, US
Sarah Teren - Madison WI, US
David J. Beebe - Monona WI, US
Eric A. Johnson - Madison WI, US
Assignee:
Wisconsin Alumni Research Foundation - Madison WI
International Classification:
G01N 33/53, G01N 33/553
US Classification:
436518
Abstract:
The present invention provides liquid crystal-based devices and methods for bioagent detection. In certain aspects, the present invention is directed to devices and methods utilizing liquid crystals and membranes containing polymerized targets that can report the presence of bioagents including, but not limited to, enzymes, antibodies, and toxins.
Composition Active Against Botulism
US Patent:
5393545, Feb 28, 1995
Filed:
Feb 3, 1993
Appl. No.:
8/013072
Inventors:
Eric A. Johnson - Madison WI
Ernani Dell'Acqua - Milan, IT
Ernani Dell'Acqua - Milan, IT
Assignee:
Solchem Italiana S.p.A. - Milan
International Classification:
A23B 400, A23B 700
US Classification:
426268
Abstract:
This invention relates to a composition of food having animal and/or vegetable origin which contains lysozyme and a chelating agent in amounts that are effective at preventing contamination of the food by Clostridium botulinum.